BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 30232757)

  • 1. Microbiota and Aging.
    Lu M; Wang Z
    Adv Exp Med Biol; 2018; 1086():141-156. PubMed ID: 30232757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linking Microbiota to Human Diseases: A Systems Biology Perspective.
    Wu H; Tremaroli V; Bäckhed F
    Trends Endocrinol Metab; 2015 Dec; 26(12):758-770. PubMed ID: 26555600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk.
    Miele L; Giorgio V; Alberelli MA; De Candia E; Gasbarrini A; Grieco A
    Curr Cardiol Rep; 2015 Dec; 17(12):120. PubMed ID: 26497040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiome R&D and Business Collaboration Forum, April 11-12, 2016, London, UK.
    Le DH
    EBioMedicine; 2016 May; 7():2-3. PubMed ID: 27322443
    [No Abstract]   [Full Text] [Related]  

  • 5. Gut Microbiota as a Therapeutic Target for Metabolic Disorders.
    Okubo H; Nakatsu Y; Kushiyama A; Yamamotoya T; Matsunaga Y; Inoue MK; Fujishiro M; Sakoda H; Ohno H; Yoneda M; Ono H; Asano T
    Curr Med Chem; 2018; 25(9):984-1001. PubMed ID: 28990516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The gut microbiota as a novel regulator of cardiovascular function and disease.
    Battson ML; Lee DM; Weir TL; Gentile CL
    J Nutr Biochem; 2018 Jun; 56():1-15. PubMed ID: 29427903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes.
    Scheithauer TPM; Rampanelli E; Nieuwdorp M; Vallance BA; Verchere CB; van Raalte DH; Herrema H
    Front Immunol; 2020; 11():571731. PubMed ID: 33178196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota and type 2 diabetes mellitus.
    Muñoz-Garach A; Diaz-Perdigones C; Tinahones FJ
    Endocrinol Nutr; 2016 Dec; 63(10):560-568. PubMed ID: 27633134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gut microbiota and metabolic disease: current understanding and future perspectives.
    Arora T; Bäckhed F
    J Intern Med; 2016 Oct; 280(4):339-49. PubMed ID: 27071815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The relationship between gut microbiota and cardiovascular diseases].
    Gerardi V; Del Zompo F; D'Aversa F; Gasbarrini A
    G Ital Cardiol (Rome); 2016 Jan; 17(1):11-4. PubMed ID: 26901254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irritable bowel syndrome, the microbiota and the gut-brain axis.
    Raskov H; Burcharth J; Pommergaard HC; Rosenberg J
    Gut Microbes; 2016 Sep; 7(5):365-83. PubMed ID: 27472486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the gut microbiome and its metabolites in metabolic diseases.
    Wu J; Wang K; Wang X; Pang Y; Jiang C
    Protein Cell; 2021 May; 12(5):360-373. PubMed ID: 33346905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The gut microbiome and irritable bowel syndrome: State of art review.
    Salem AE; Singh R; Ayoub YK; Khairy AM; Mullin GE
    Arab J Gastroenterol; 2018 Sep; 19(3):136-141. PubMed ID: 29935865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut Microbiota, Bacterial Translocation, and Interactions with Diet: Pathophysiological Links between Major Depressive Disorder and Non-Communicable Medical Comorbidities.
    Slyepchenko A; Maes M; Jacka FN; Köhler CA; Barichello T; McIntyre RS; Berk M; Grande I; Foster JA; Vieta E; Carvalho AF
    Psychother Psychosom; 2017; 86(1):31-46. PubMed ID: 27884012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota and obesity: lessons from the microbiome.
    Cani PD
    Brief Funct Genomics; 2013 Jul; 12(4):381-7. PubMed ID: 23616309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiota and Subclinical Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus.
    Tsai HJ; Tsai WC; Hung WC; Hung WW; Chang CC; Dai CY; Tsai YC
    Nutrients; 2021 Aug; 13(8):. PubMed ID: 34444839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics, gut microbiota and health.
    Butel MJ
    Med Mal Infect; 2014 Jan; 44(1):1-8. PubMed ID: 24290962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal microbiota transplantation for gastrointestinal disorders.
    Malikowski T; Khanna S; Pardi DS
    Curr Opin Gastroenterol; 2017 Jan; 33(1):8-13. PubMed ID: 28134687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Microbiome, diabetes and heart: a novel link?].
    Kappel BA; Lehrke M
    Herz; 2019 May; 44(3):223-230. PubMed ID: 30847506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.